I expect the company may wait for formal minutes of meeting to be released - which the FDA does within 30 days. Or, maybe we get lucky and the company whips up an announcement before hand and we get something next week.
Either way, we should expect an update by end of April at the latest on this meeting.
DXB Price at posting:
47.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)